Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
20,283,687
-
Shares change
-
+1,369,223
-
Total reported value, excl. options
-
$283,967,278
-
Value change
-
+$21,355,133
-
Number of buys
-
50
-
Number of sells
-
-21
-
Price
-
$14
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2020
90 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q4 2020.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,283,687 shares
of 88,059,438 outstanding shares and own 23.03% of the company stock.
Largest 10 shareholders include BVF INC/IL (3,226,769 shares), Canaan Partners X LLC (2,660,713 shares), BOXER CAPITAL, LLC (2,202,812 shares), RTW INVESTMENTS, LP (1,846,843 shares), 5AM Venture Management, LLC (1,798,066 shares), BlackRock Inc. (1,214,070 shares), Point72 Asset Management, L.P. (1,111,111 shares), FEDERATED HERMES, INC. (1,098,348 shares), Alphabet Inc. (753,187 shares), and VANGUARD GROUP INC (717,581 shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.